Visceral artery aneurysms: a literature review of etiology, natural history, diagnosis and treatment paradigms Authors: Mehreet Kaur Chahal, Amrit Khooblall, Ramanpreet Singh, Amanjit Gill, Sameer Gadani Published: 2026 ABSTRACT AbstractBackground and ObjectiveVisceral artery aneurysms (VAAs) are rare but clinically significant vascular lesions associated with high mortality following rupture, estimated at 25–75%. Increased use of modern imaging has improved incidental detection of asymptomatic aneurysms. This review summarizes the etiology, natural history, diagnosis, and evolving management strategies of VAAs, with emphasis on territory-specific endovascular and surgical approaches.MethodsA structured literature review was conducted using PubMed/MEDLINE, EBSCO, and the Cochrane Library to identify studies published between 2010 and 2025 on the diagnosis and management of VAAs. Original studies, systematic reviews, meta-analyses, and selected case reports were reviewed and synthesized.Key Content and FindingsVAAs often remain asymptomatic until rupture, whereas pseudoaneurysms carry significantly higher rupture risk and require urgent treatment regardless of size. Diagnosis relies primarily on computed tomography angiography (CTA), magnetic resonance imaging (MRI), ultrasound (US), and catheter angiography. Management depends on aneurysm morphology, location, rupture status, symptoms, and patient-specific risk factors. Endovascular therapy has become the preferred treatment modality in most anatomically suitable cases because of its minimally invasive nature and high technical success. Common techniques include coil embolization, stent-assisted and balloon-assisted embolization, liquid embolic agents, covered stents, and flow-diverting stents. Surgical and hybrid approaches remain important in cases of rupture, complex anatomy, or failed endovascular therapy.ConclusionsAdvances in imaging and interventional radiology have transformed VAA management, with endovascular approaches increasingly favored over open surgery in appropriately selected patients. Individualized, multidisciplinary management remains essential for optimizing outcomes.Keywords: Visceral artery aneurysms (VAAs), aneurysm rupture, pseudoaneurysm, endovascular repair, open surgical repair Introduction Visceral artery aneurysms (VAAs) are rare but clinically significant vascular pathologies with a prevalence of 0.01% to 0.2% (1). These aneurysms affect the splanchnic arteries, including the celiac axis and its branches and the superior and inferior mesenteric arteries and their branches. Anatomically speaking, VAAs can be true aneurysms, involving all the layers of the vessel wall with focal dilation of an artery >50% of the expected diameter for the given anatomical location and sex of the patient; pseudoaneurysms, occurring as a defect in the arterial wall that communicates with the lumen but lacking all 3 layers of the vessel; or dissecting aneurysms, which are associated with connective tissue disorders (2). The natural history of VAAs is benign; however, these aneurysms carry a high risk of rupture with an associated mortality of 25% to 75% (1), so prompt identification, diagnosis, and management are necessary to decrease mortality from these lesions. Past treatment options for VAAs were mainly limited to surgical repair techniques such as ligation, resection, or bypass. However, over the past 2 decades, endovascular and interventional radiology (IR) techniques have emerged as the treatment of choice for most VAAs, offering a minimally invasive alternative to open surgery. These techniques are also associated with lower postoperative mortality, improved preservation of organ function, and higher success rates in high-risk cases (e.g., elderly patients and those with comorbid conditions). The silent nature of VAAs until rupture makes the performance of prospective longitudinal studies a challenge; therefore, most of the literature on VAAs has involved retrospective studies. This article aims to present a comprehensive review of this literature to equip physicians with a detailed understanding of etiology, pathophysiology, epidemiology, clinical presentation, diagnosis, and management of VAAs. The article discusses the changing landscape of therapy for VAAs, emphasizing the shift toward endovascular approaches, which offers a unique clinical perspective regarding territory specific interventions and risk stratification. We aim to discuss VAA management in an algorithmic approach with detailed tabulated information about specific anatomical considerations. By integrating nuanced technical details along with case images and societal guidelines, we aim to offer a high-utility clinical resource for the modern multidisciplinary vascular team. We present this article in accordance with the Narrative Review reporting checklist (available at https://cdt.amegroups.com/article/view/10.21037/cdt-2025-1-666/rc). Methods A comprehensive and structured literature search was conducted across multiple electronic databases, including PubMed/MEDLINE, EBSCO, and the Cochrane Library, to identify peer-reviewed publications on the management of VAAs. The search strategy incorporated a combination of keywords and Boolean operators, including “visceral artery aneurysm”, “splenic artery aneurysm (SAA)”, “hepatic artery aneurysm (HAA)”, “superior mesenteric artery aneurysm (SMAA)”, “celiac artery aneurysm”, “surgical management”, “open repair”, “endovascular treatment”, and “treatment paradigms”. To capture both foundational and contemporary evidence, the search spanned publications from 2010 to 2025, with particular emphasis on studies from the past 5 years. Study selection followed a multi-stage approach. Titles and abstracts were initially screened for relevance to the surgical and interventional management of VAAs, followed by full-text review of eligible articles to confirm inclusion of major VAA subtypes (SAA, HAA, SMAA, and celiac artery aneurysms). Inclusion criteria were based on relevance, time frame, peer-reviewed original research (including clinical series and cohort studies), systematic reviews, meta-analyses, and select case reports offering significant clinical or anatomical insights. Only English-language articles were included. Additionally, reference lists of key articles were manually screened to identify further relevant studies. Data extraction focused on key clinical parameters, which were synthesized into a structured, territory-based framework. Extracted variables included epidemiology and prevalence, natural history and rupture risk, indications for intervention (including size thresholds and symptomatology), management strategies (open versus endovascular approaches), and reported clinical outcomes such as technical success and perioperative morbidity and mortality. This methodology enabled a comparative and comprehensive analysis of contemporary management paradigms across different visceral artery aneurysm subtypes. A structured summary of the search strategy and study selection process is presented in Table 1. Table 1The search strategy summaryItemsSpecificationDate of search June 15, 2025DatabasesPubMed/MEDLINE, EBSCO, and the Cochrane LibrarySearch terms usedMeSH terms included “Aneurysm”, “Endovascular Procedures”, and “Embolization, Therapeutic”. Free text terms included “visceral artery aneurysm”, “splenic artery aneurysm”, “hepatic artery aneurysm”, “superior mesenteric artery aneurysm”, “coil embolization”, “endovascular repair”, and “surgical repair”. Filters applied: English language, human studies, publication years 2010–2025TimeframeJanuary 1, 2010–January 1, 2025Inclusion and exclusion criteriaIncluded peer-reviewed original studies, systematic reviews, meta-analyses, and selected case reports published in English. Non-English articles, conference abstracts without full text, and unrelated studies were excludedSelection process Titles and abstracts were screened for relevance, followed by full-text review of eligible articles. Studies were selected based on relevance to epidemiology, diagnosis, natural history, and management of visceral artery aneurysmsAdditional considerationsReference lists of key articles were manually screened to identify additional relevant studies The search strategy summary Etiology and pathophysiology Risk factors for the development of VAAs include atherosclerosis, hypertension, inflammatory vasculopathies, trauma or iatrogenic injury, pancreatitis and enzyme leakage, infections, and genetic disorders. Immunoglobulin G4 vasculopathy can also have a presentation involving multiple aneurysms in some cases (3). Additionally, VAAs may occur in patients with rare diseases such as von Recklinghausen disease (neurofibromatosis type 1), Ehlers-Danlos syndrome, polyarteritis nodosa, and Behçet disease (4-12) (Table 2). Table 2Etiology and pathophysiology of VAAsEtiology Pathophysiology Morphological subtype Commonly involved arteries Key featuresAtherosclerosis, hypertension (5) Degeneration of the arterial wall True, fusiform Superior mesenteric (usually proximal segment), celiac Slow-growing aneurysmsConnective tissue disorders (Marfan syndrome, Ehlers-Danlos syndrome, fibromuscular dysplasia, Osler-Weber-Rendu syndrome) (5) Congenital weakness of the vessel wall True, fusiform, usually multiple Multiple (splenic) Occurs in relatively younger patientsChronic inflammation (pancreatitis, cholecystitis) (6) Inflammation-mediated damage to the vessel wall Pseudoaneurysms, saccular Hepatic, splenic, pancreatoduodenal, gastroduodenal Irregular contour, usually presents with hemorrhageMycotic aneurysms (7) Infection-mediated vessel wall erosion, associated with endocarditis and septicemia Pseudoaneurysms, saccular Splenic, hepatic, superior mesenteric High risk of rupture, inflammatory fat stranding, rapid enlargementPolyarteritis nodosa, lupus, Takayasu disease, Behçet syndrome, SAM (8) Inflammatory vessel wall destruction. SAM is characterized by vacuolar degeneration of smooth muscle cells in media followed by lysis True, multiple, saccular, dissecting Hepatic, superior mesenteric, splenic SAM associated with intracranial aneurysmsPregnancy and portal hypertension Hyperdynamic flow leads to aneurysmal formation. Hormonal changes and increased arteriovenous shunting during pregnancy (9) True, saccular Splenic predominance, less commonly hepatic High risk of rupture in pregnancy, associated with high fetal and maternal mortality (10)Iatrogenic injury, trauma (penetrating/blunt trauma, liver transplant, endoscopic retrograde cholangiopancreatography, pancreatic and biliary surgery) Focal disruption of the arterial wall creating an unstable sac Pseudoaneurysms, irregular, saccular Hepatic, pancreaticoduodenal Associated with dramatic delayed gastrointestinal hemorrhageMedian arcuate ligament syndrome, celiac compression (11) Mechanical compression with collateral hypertrophy True, fusiform Pancreaticoduodenal, gastroduodenal (12) Treatment of underlying compression improves outcomesSAM, segmental arterial mediolysis. Etiology and pathophysiology of VAAs SAM, segmental arterial mediolysis. The morphology of the aneurysm provides essential diagnostic and prognostic information in terms of therapeutic choice and procedural strategy. For instance, pseudoaneurysms carry a higher risk of rupture regardless of size and thus mandate urgent intervention. Other information such as the presence or absence of calcification, thrombosis, and dissection can help clinicians to determine not only the treatment category but also the potential causes. The natural history of VAAs remains incompletely understood due to their rarity and typically silent presentation, contributing to variability and conflicting management recommendations across studies and international guidelines. However, available retrospective data, including a large single-institution study suggest a predominantly benign course, with slow growth rates (~0.06–0.6 mm/year) and low rupture risk in small, asymptomatic aneurysms, particularly those <2–2.5 cm, which can be safely managed with surveillance (13). Rupture risk is multifactorial, influenced by aneurysm size, location, and etiology, and should not be extrapolated from ruptured cases alone. Although rupture can occur and carries significant morbidity, it is more commonly associated with larger or symptomatic aneurysms, supporting a selective, risk-stratified approach to intervention. Given the heterogeneity of available data, this review adheres to Society for Vascular Surgery (SVS) guidelines to ensure consistency and minimize variability in recommendations. Clinical presentation and diagnosis Clinical presentation When VAAs are symptomatic, their presentation varies widely depending on the aneurysm size, location, and rupture status. Common clinical manifestations include nonspecific abdominal pain, gastrointestinal bleeding, and the presence of a palpable pulsatile mass. Aneurysms larger than 5 cm can present with compression symptoms such as abdominal discomfort, lumbar pain, and even jaundice (14,15). In rare cases, symptoms such as obstructive jaundice, hemobilia, or ischemic bowel can indicate an aneurysm involving arteries such as the hepatic, gastroduodenal, or mesenteric vessels. HAAs can rarely present with jaundice, biliary colic, and gastrointestinal hemorrhage (Quincke’s triad) (16). Ruptured VAAs may present with hypotension, syncope, or hemorrhagic shock and carry a high risk of morbidity and mortality if not promptly addressed. Diagnosis Diagnostic workups are similar for true aneurysms and pseudoaneurysms and may include imaging modalities such as ultrasound (US), computed tomography angiography (CTA), and magnetic resonance imaging (MRI). Radiographs often have limited use unless atherosclerotic aneurysms have shell-like calcifications, especially in SAAs (17). US is often used as the initial screening tool for VAAs, especially for more superficial aneurysms. Although Doppler US is often used for abdominal aortic aneurysm screening, this technique has limited diagnostic accuracy for VAAs because of hindrance from bowel gas and fat (18). Low-frequency US probes may show pseudoaneurysms as ovoid or round anechoic structures with a bidirectional waveform. True aneurysms often appear as round hypoechoic lesions and, depending on the size of the thrombus, perfused masses (19,20). Multidetector CTA is a frequently used technique that is highly sensitive in detecting VAAs. Multiphase scans (precontrast, arterial phase, venous phase, and delayed phase images) offer a panoramic view of the pathology, and arterial phase images are helpful in locating extravasation and thus guiding treatment decisions. Note that narrow-neck true aneurysms may not be visible in the arterial phase, but pseudoaneurysms are usually visible in both the arterial and venous phases. CTA is also useful for detecting complications post treatment and performing surveillance. Additionally, a single-center study by Berczeli et al. (11) demonstrated that intraoperative cone-beam CTA (CBCTA) after selective intra-arterial contrast injection is able to provide optimal information for planning at a reasonable radiation exposure. MRI is usually not the initial choice to analyze vasculature, but this modality can be useful for patients with contrast allergies or kidney dysfunction. Magnetic resonance (MR) angiography has shown potential for the characterization of VAAs because the difference in T1 relaxation times between vascular structures and the surrounding tissues after contrast administration allows for high contrast resolution. MR techniques can also be useful for follow-up, especially in patients with platinum coils, as these coils tend to lead to streak artifacts on computed tomography (CT) (21,22). The main disadvantages of MR techniques are longer acquisition times and issues regarding patient compliance, specifically patient movement due to long acquisition times. Management Treatment options for VAAs depend on factors such as the hemodynamic stability of the patient, the size of the aneurysm, the presence of any associated comorbidities (e.g., hypertension), pregnancy status in individuals of reproductive age, evidence of an expanding aneurysm on serial imaging, and the presence of portal hypertension. Treatment usually involves an endovascular approach or a surgical approach, with some patients treated with hybrid techniques utilizing both methods. Indications for treatment are as follows (23,24): ❖ SVS (further explained territory-wise in the “Discussion” section); ❖ SVS (further explained territory-wise in the “Discussion” section); ❖ Urgent treatment for symptomatic VAAs and visceral artery pseudoaneurysms; ❖ Urgent treatment for symptomatic VAAs and visceral artery pseudoaneurysms; ❖ VAAs of the pancreaticoduodenal, gastroduodenal, mesenteric, or colic arteries irrespective of their size; ❖ VAAs of the pancreaticoduodenal, gastroduodenal, mesenteric, or colic arteries irrespective of their size; ❖ Intrahepatic HAAs; ❖ Intrahepatic HAAs; ❖ Individuals of child-bearing age with VAAs; ❖ Individuals of child-bearing age with VAAs; ❖ Liver transplant recipients with VAAs; ❖ Liver transplant recipients with VAAs; ❖ VAAs with growth ≥0.5 cm/year. ❖ VAAs with growth ≥0.5 cm/year. The surgical or endovascular treatment of patients with other asymptomatic VAAs is recommended only if the diameter of the aneurysm is >25 mm (Figure 1). Flowchart summarizing treatment intervention indications. The dotted line indicates an alternative/exception pathway. CT, computed tomography; CTA, computed tomography angiography; MRI, magnetic resonance imaging; VAA, visceral artery aneurysm. Surgical interventions Even with the growing dominance of endovascular therapy and its various techniques (as discussed in the next section), surgery remains indispensable in select cases, particularly when anatomical constraints, device limitations, or emergent rupture preclude endovascular management (2,4,12,18,25-38) (Table 3). Open surgery also offers the surgeon the ability to address downstream ischemia (e.g., resecting infarcted bowel or restoring flow), which can be critical in rupture scenarios. Managing VAAs therefore involves balancing endovascular convenience against the definitive control that can be achieved with open surgery. Table 3Territory specific overview for VAAsType of VAAPrevalence and epidemiology (4,12,18,33-35)Rupture risk (4,12,18,33-35)Indications for invasive interventions (2)Preferred endovascular approach (4,12,18,33-35)Surgical approachSplenic artery aneurysm60–80% of all VAAs; ~25% occur during pregnancy; 4:1 female predominanceIncreased rupture risk for aneurysms >2–3 cm; risk markedly higher in third-trimester pregnancy (~75% maternal, >90% fetal mortality); portal hypertension is a risk factorAsymptomatic true aneurysms >3 cm (grade II, level C) or growth >0.5 cm/year; nonruptured aneurysms of any size in individuals of childbearing age; aneurysms in liver transplant candidatesCoil embolization (sandwich technique proximal + distal occlusion); liquid embolic agents for large, high-flow lesions; distal/hilar lesions are at risk of splenic infarctOpen surgery (often splenectomy with arterial ligation or bypass); this is generally reserved for cases unsuited to endovascular repair or in emergencies such as rupture (25)Hepatic artery aneurysm20% of all VAAs; most commonly observed during the 6th decade of life; 3:2 male predominanceRupture risk of 14–80%; pseudoaneurysms carry a high rupture risk and are usually extrahepaticAsymptomatic true aneurysms >2 cm or growth >0.5 cm/yearCovered stent exclusion for extrahepatic lesions; coil embolization for distal/intrahepatic lesionsOpen surgical repair typically involves aneurysm excision with arterial reconstruction (e.g., graft interposition); a vital option when endovascular exclusion is infeasible (26)Superior mesenteric artery aneurysm6.7–6.9% of all splanchnic artery aneurysmsRupture risk of 38–50% with mortality of ~30–90% in untreated cases (28)All aneurysms regardless of size (grade 1A)Covered stent grafting if anatomy allows; flow-diverting stent placement; liquid embolic agents can be used when collateral circulation is adequate; angiographic mapping of the mesenteric collaterals is crucialOpen surgical repair is often recommended and usually involves aneurysmectomy with revascularization (bypass or interposition graft) to maintain mesenteric perfusion (27)Celiac arteryaneurysm4–5% of all VAAsRupture risk ~10–20%; increased risk with larger aneurysm size; mortality with rupture ~50%Asymptomatic true aneurysms >2 cm; aneurysms in individuals of child-bearing age and transplant candidates regardless of aneurysm sizeCoil embolization or covered stent placement; endovascular repair is challenging when the aneurysm involves the origin of the celiac arterySurgical repair often entails aneurysmectomy with revascularization (e.g., bypass grafting from the aorta to the hepatic and/or splenic artery) to maintain organ perfusion (26)Gastroduodenal artery aneurysm1–4% of all VAAsUp to 75% rupture risk; risk generally unrelated to aneurysm sizeAll aneurysms regardless of sizeCoil embolization; concomitant celiac artery occlusion may cause hepatic ischemiaOpen surgery (aneurysmectomy with arterial ligation or bypass) is less commonly performed except when endovascular methods fail or are contraindicated; a hybrid approach is often employed (30)Pancreaticoduodenal artery aneurysm<2% of all VAAsUp to 75% rupture risk; risk appears independent of aneurysm size and is associated with male sexAll aneurysms regardless of sizeCoil embolization; concomitant celiac artery occlusion may cause hepatic ischemiaOpen surgery is indicated for emergent ruptures or when endovascular access is not possible (29)Renal artery aneurysms (2,36-38)Estimated at 0.1–1% in the general population, increasing to 2.5% in hypertensive or angiographic cohortsHistorically reported at <5% for asymptomatic, non-pregnant patients. Risk increases with pregnancy, inflammatory etiology and diameterRepair suggested when diameter is >3 cm in asymptomatic patients with acceptable operative risk, any size if symptomatic, ruptured or women with childbearing potentialBoth proximal stent-grafting and distal embolization of renal artery aneurysms are established techniques with high rates of technical success and low procedural morbidity. Advanced remodelling techniques including balloon-assisted or stent-assisted coiling or flow-diverting stentsOpen reconstruction remains the choice for complex hilar bifurcations involving multiple branches; techniques employed include resection with primary arteriorrhaphy, patch angioplasty, or bypass using autogenous veinJejunal artery aneurysm (32)<1% of all VAAsRupture risk ~60%Asymptomatic aneurysms >2 cmCoil embolization; use of packing and isolation techniques improves outcomesLow threshold to proceed to open repair if any doubt exists regarding completeness of exclusion or bowel perfusion (31)VAA, visceral artery aneurysm. Territory specific overview for VAAs VAA, visceral artery aneurysm. SAAs are the most common VAA, and carry a serious rupture risk, particularly in pregnancy. Outcomes for open versus endovascular repair of SAAs are broadly similar in case of ruptured SAA in terms of morbidity and mortality, with one systematic review demonstrating no significant difference in overall mortality for patients with ruptured SAAs (open surgery, ~12.9%; endovascular repair, ~7.8%; P=0.84) (25). HAAs constitute the second most prevalent VAA and pose unique surgical challenges due to the need to preserve hepatic blood flow and avoid biliary ischemia (26). Open surgical repair typically involves aneurysm excision with arterial reconstruction. In a recent single-center series, open repair achieved excellent long-term results at the cost of higher perioperative morbidity (open surgery, 32% complication rate; endovascular repair, 18% complication rate). The 5-year primary patency of graft reconstructions was ~90% with a 5-year overall survival of ~81%, highlighting the durability of open surgery (26). Critical organ perfusion must also be safeguarded in patients with SMAAs. These aneurysms are uncommon but clinically feared due to a historically high propensity for rupture. When feasible, endovascular repair can be lifesaving in instances of rupture or in high-risk patients, but open surgery remains indispensable for cases of rupture with hemodynamic instability or when arterial reconstruction is required to prevent bowel ischemia (28). Thus, open surgical repair is often recommended, especially for anatomically complex aneurysms, to maintain mesenteric perfusion. In one 30-year series in 131 patients, one-third of SMAAs were managed operatively (predominantly open), yielding a 2% perioperative mortality and ~25% complication rate (27). Notably, no ruptures occurred during long-term follow-up in patients with small degenerative SMAAs (<20 mm) who were managed conservatively. This observation suggests that truly small, stable aneurysms might be monitored in select cases, although such practice must be weighed against the catastrophic outcomes of rupture. Indeed, most surgeons err on the side of early intervention. Celiac artery aneurysms are rare but clinically significant because of the critical vascular territory they supply (liver, spleen, and stomach) (26). Open surgical repair of these aneurysms often entails resection of aneurysm with revascularization to maintain organ perfusion. Despite the invasiveness of this procedure, open reconstruction has demonstrated durable outcomes; in a contemporary series (combined with HAA cases), open graft repairs demonstrated 90% primary patency at 5 years and low aneurysm-related mortality. Alternatively, some of these aneurysms can be treated by simple ligation or stent-graft placement if robust collateral flow exists (as the liver can sometimes be perfused via the pancreaticoduodenal arcade from the superior mesenteric artery). Long-term results appear comparable between open and endovascular approaches in terms of survival, so the choice of technique hinges on patient factors and aneurysm anatomy (26). Gastroduodenal artery aneurysms are exceedingly uncommon, but they demand prompt attention when identified due to high rupture potential. In general, open surgery is used to treat these aneurysms only when endovascular methods fail or are contraindicated. Importantly, some gastroduodenal artery aneurysms arise in the context of celiac trunk stenosis, where the gastroduodenal artery-pancreaticoduodenal arcade becomes a critical collateral pathway (29,39). In such cases, simply embolizing the aneurysm without restoring flow to the celiac axis can precipitate visceral ischemia. A 2020 study highlighted this concern: in aneurysms of the gastroduodenal artery-pancreaticoduodenal arcade caused by celiac occlusion, lack of surgical revascularization led to visceral ischemia in several patients, with 3 requiring urgent open bypass after initial embolization (30). Therefore, a hybrid approach that combines endovascular aneurysm exclusion with concurrent surgical revascularization of the celiac artery may be needed to treat gastroduodenal artery aneurysms in the collateral setting. Closely related to gastroduodenal artery aneurysms are pancreaticoduodenal artery aneurysms, which often coexist with celiac stenosis and similarly challenge the surgeon to preserve vital collateral circulation. Elevated flow through the pancreaticoduodenal collaterals (inferior and superior pancreaticoduodenal arteries, often including the gastroduodenal artery) underlies many of these aneurysms (30). This scenario is classically seen in median arcuate ligament syndrome, and it indicates that the aneurysm is part of the only supply route to the liver and spleen. The high rupture risk of pancreaticoduodenal artery aneurysms warrants intervention in virtually all cases. Historically, open surgical repair (aneurysm resection with arterial reconstruction or ligation) was standard. Open surgery is still indicated in emergent ruptures or when endovascular access is not possible. However, modern management has trended toward endovascular and hybrid approaches. In a recent series of 9 patients with pancreaticoduodenal artery aneurysms (nearly all with concomitant celiac stenosis), all were successfully treated with endovascular or combined endovascular-surgical techniques. The outcomes were excellent, including 100% technical success and no instances of procedure-related morbidity, mortality, or need for reintervention at medium-term follow-up (2 years) (29). These results suggest that a tailored hybrid approach can be used to definitively manage the aneurysm while simultaneously addressing the underlying celiac lesion; however, careful patient selection is critical. Endovascular occlusion of a pancreaticoduodenal artery aneurysm alone is appropriate only if collateral circulation is sufficient or if celiac flow is restored by other means. Otherwise, surgical revascularization (e.g., celiac bypass) should accompany aneurysm treatment to prevent ischemic complications (30). Jejunal artery aneurysms are exceedingly rare. In one large review of 2,845 VAAs, only 15 aneurysms of the jejunal/ileal/colic branches were documented (40). Most jejunal artery aneurysms are discovered incidentally or at rupture, as they seldom produce specific symptoms. Because of their rarity, management is based on principles rather than on high-level evidence. Endovascular therapy is the preferred first-line treatment when anatomically feasible (31,32). However, open surgery retains an important role. Jejunal artery aneurysms that are not amenable to catheter-based therapy (because of unfavorable anatomy such as a wide neck or tortuous origin) are managed with open resection of the aneurysm and arterial reconstruction if needed. In one published case, a saccular proximal jejunal artery aneurysm (~17 mm) was surgically resected and the artery repaired with a saphenous vein graft interposition (31). As highlighted by this case and a few other published cases, reported outcomes for JAA interventions have been favorable (31). Overall, given the paucity of data, these aneurysms should be approached on a case-by-case basis. The consensus is to treat them whenever identified (due to the potential for rupture and hemorrhage into the mesentery or gastrointestinal tract), typically via endovascular means, if possible, with a low threshold to proceed to open repair if any doubt exists regarding the completeness of exclusion or bowel perfusion. Endovascular management Endovascular repair of VAAs has emerged as the preferred modality and is considered first-line treatment, especially in emergent settings (41). In anatomically suited patients, endovascular repair should be the preferred method even in elective cases (10). Below we discuss commonly used endovascular techniques and devices used for management. Access sites for endovascular repair include the common femoral artery, which is standard for most procedures; radial or distal transradial access (dTRA) is used in tortuous anatomy or to avoid the Common femoral artery in obese or coagulopathic patients. Wada et al. (42) reported successful embolization of SAAs via dTRA and commented on the feasibility of using dTRA in noncardiac interventions. Less frequently, brachial arteries can also be used for access. Various endovascular techniques are used for the management of VAAs; the choice of technique depends on the type and size of the aneurysm, the distal vascular bed, and the complexity of the anatomy (Table 3) (2,4,12,18,25-38). Types of endovascular techniques employed Coil embolization Coil embolization is the most frequently used technique for endovascular management of VAAs, with a technical success rate ranging from 84.2% to 98.3% (43). Coil embolization techniques include sac packing, the isolation technique, and the sandwich technique. In sac packing, coils are placed within the aneurysm sac to induce thrombosis (5), the principle is to fill the sac with a larger coil and make a “basket” followed by a smaller coil. This technique is typically used in patients with saccular aneurysms or pseudoaneurysms with a narrow neck. In cases of fusiform aneurysms, coil embolization of the aneurysm without occlusion of the artery may also not be feasible (44). In the isolation technique, both the afferent and efferent vessels are occluded. The sandwich technique involves sac packing plus distal and proximal parent vessel occlusion. The isolation and sandwich techniques can be used to treat saccular aneurysms with a wide neck and fusiform aneurysms. Typically, the goal of coil embolization is to preserve arterial patency. In cases treated with coil embolization, using an appropriately sized coil in reference to the size of the aneurysm and arterial lumen is critical to achieve optimal outcomes. Typically, 20% upsizing of the coil is recommended. Undersized coils increase the risk of inadequate occlusion and distal migration, whereas oversized coils have reduced thrombotic potential due to the lack of conformation to the size of the aneurysm or arterial lumen (45,46). The packing density of the coil is also critical in ensuring clinical success (44). Coil technology has evolved from simple pushable coils to detachable coils (including microcoils) and coils with blood vessel anchoring (POD, Penumbra Inc., Alameda, CA, USA). The initial pushable coils included fibers, which increase thrombogenicity when compared with bare platinum coils. These coils are typically deployed through either the base catheter or a microcatheter using a jet of normal saline or a coil pusher wire. Although these coils are cost-effective and lead to adequate clinical outcomes, there is a significant risk of nontarget embolization or migration of the coil to the distal vascular bed, which may complicate retrieval using a snare. Detachable coils, on the other hand, are attached to the tip of a guidewire. Once the coil is positioned in the appropriate location, it can be detached from the guidewire mechanically or by a small electrical pulse. These detachable coils can be longer (>50 cm), therefore reducing the need for multiple coils. Additionally, in most instances, these coils can be retrieved until they are detached, reducing the risk of nontarget embolization and increasing the safety profile. The Penumbra POD system can be used in medium to large arteries with high flow because the coils in this system can anchor themselves and in large caliber arteries (36). Stent-assisted coil embolization In patients with saccular aneurysms or aneurysms with a broad neck, sac embolization with coils may not be feasible without sacrificing the artery due to potential risk of protrusion and displacement of the coil pack in the arterial lumen. In such instances, using stent assistance for coil packing can preserve arterial lumen patency and therefore perfusion of the distal arterial bed. With this technique, a bare-metal stent is typically placed across the aneurysm. A microcatheter is then advanced in the aneurysm sac over a guidewire through the interstices of the stent. Coil embolization is then performed through the microcatheter, maintaining the patency of the arterial lumen. This technique may not be feasible in patients with extreme tortuous vascular anatomy, in those without adequate landing zones for the stent, or in patients with complex aneurysms. Additionally, initial dual antiplatelet therapy followed by lifelong single antiplatelet therapy may be required to maintain the patency of the stent (37,38,47). An illustrative example of this technique is shown in Figure 2, demonstrating stent-assisted coil embolization of a complex, tortuous renal artery aneurysm with a wide neck and multiple branch vessels. The use of cone beam CT planning and a dual microcatheter approach enabled precise coil deployment with successful aneurysm occlusion while preserving branch vessel patency. Stent-assisted coil embolization of a complex branch renal artery aneurysm using a dual-microcatheter technique. (A) Coronal MIP image demonstrating the tortuous aorta, with a challenging enlarging renal artery aneurysm arising from a 3rd order branch of the right renal artery, just proximal to a branch point with two relatively large outflow arteries. (B) Reconstructed image from a cone beam CT acquisition with measurements of patent portion of the aneurysm to estimate the number of coils needed to occlude the aneurysm. (C) Angiogram in a complex projection dictated by the cone beam CT to best outline/separate all the relevant branches. (D) A dual microcatheter approach, with one catheter in the major outflow branch (large blue arrow), and the other in the aneurysm sac (small black arrow). The neuroform stent was deployed across the neck of the aneurysm, trapping the microcatheter in the aneurysm. (E) Final image demonstrating complete occlusion of the aneurysm by coils (Stryker 0.010 Target coils) and patency of all the branch vessels. CT, computed tomography; MIP, maximum intensity projection. Balloon-assisted coil embolization In patients with saccular aneurysms with a broad neck, balloon-assisted coil embolization is an alternative treatment option. With this technique, a microcatheter is parked in the saccular aneurysm and a balloon of adequate length is advanced in the artery across the neck of the aneurysm. The balloon is inflated at the time of deployment of the coil to assist in packing the aneurysm without allowing the coils to protrude in the lumen. The coil is detached only when the stability of the coil within the aneurysm has been confirmed after the balloon is deflated. Multiple coils can be deployed within the aneurysm with intermittent inflation and deflation of the balloon, assuring the patency of the native artery and therefore perfusion of the distal vascular territory. Antiplatelet therapy is not required with this technique since a stent is not placed in the native artery. However, there is a potential risk of native artery thrombosis during embolization if balloon inflation is prolonged. This risk can be minimized by reducing the inflation time of the balloon and by administering heparin during the procedure (48). Figure 3 illustrates balloon-assisted coil embolization, demonstrating temporary balloon inflation across the aneurysm neck to facilitate stable coil deployment within the sac while preserving parent artery patency. Balloon-assisted coil embolization of a transplant hepatic artery pseudoaneurysm following post-angioplasty rupture. (A) Diagnostic angiogram of the transplant hepatic artery reveals focal severe narrowing (marked by an arrow) at the anastomosis. (B) Post angioplasty of the narrowed segment revealed a pseudoaneurysm formation due to contained rupture of the artery (marked by an arrow). (C) Fluoroscopic image showing a microcatheter (marked by red arrow) placed in the pseudoaneurysm and a balloon catheter across the neck of the aneurysm in the arterial lumen (marked by yellow arrows). (D) Schematic representation of advanced microcatheter, balloon and guidewire. (E) Placement of the coil through the microcatheter trapped in the pseudoaneurysm (marked with black arrow) while the balloon is expanded across the neck the aneurysm (marked with yellow arrow). (F,G) Schematic illustrations showing “framing coils” with inflated balloon followed by deflation of the balloon after confirmation of coil stability. (H) Hepatic angiogram after balloon assisted coil embolization of the pseudoaneurysm with complete obliteration of the pseudoaneurysm sac, final outcome represented schematically by (I). Embolization with adhesive and nonadhesive liquid embolic agents Adhesive liquid embolic agents can be used for embolization in select cases, including pseudoaneurysms (49,50). A frequently used adhesive embolic material is N-butyl cyanoacrylate, which is mixed with lipiodol to control polymerization time and impart radiopacity. However, there is a high risk of nontarget embolization with this technique due to escape of the embolic material in the distal vascular bed leading to ischemia. Additional risks include entrapment of the catheter within the aneurysm due to the adhesive property of the embolic material, as well as distant nontarget embolization caused by adhesion of residue at the tip of the catheter during retraction. Nonadhesive liquid embolic agents are typically used in neurointerventions to treat intracranial vascular malformations and aneurysms. However, these agents are increasingly being used in non-neurointerventional applications. One such agent is ethylene vinyl alcohol copolymer mixed with micronized tantalum powder and dissolved in dimethyl sulfoxide (Onyx, Medtronic, Minneapolis, MN, USA; and Lava, Sirtex Medical, Woburn, MA, USA). These agents offer several advantages over N-butyl cyanoacrylate, including their viscous nature, slow polymerization time, excellent fluoroscopic visibility, ability to homogeneously fill the vessel, and nonadherence to the microcatheter tip, which imparts a lower risk of nontarget embolization. These embolic materials can also be used along with other embolic devices to enhance their occlusion capability (51,52). Higher cost, need for longer preprocedural preparation (approximately 20 min of shaking), and risk of dimethyl sulfoxide endothelial toxicity leading to vasospasm and pain are potential disadvantages of these nonadhesive agents. Stent-graft implantation Polytetrafluoroethylene (PTFE)-covered stents exclude the aneurysm from the arterial lumen, thereby leading to thrombosis of the aneurysm while maintaining arterial patency. Typically, this technique is used for patients with saccular aneurysms, pseudoaneurysms with a broad neck, or fusiform aneurysms (when the anatomy is favorable). In a large series of 100 patients with VAAs, endovascular PTFE-covered stent placement was feasible in 30% of the cases, whereas transcatheter embolization was feasible in 70% (53). Inadequate landing zones, relatively small arteries, and extensive tortuosity are limitations for stent placement. The covered stents can be balloon-mounted or self-expanding. Typically, self-expanding stents (e.g., Viabahn, W.L. Gore, Flagstaff, AZ, USA; and Fluency, Becton, Dickinson and Company, Franklin Lakes, NJ, USA) can adapt to vessel tortuosity due to their lack of shape memory and high flexibility. Balloon-expandable covered stents (iCast, Atrium, Merrimack, NH, USA), on the other hand, are usually more rigid and less suitable for tortuous vessels. For more peripheral VAAs from relatively smaller arteries (5 mm), coronary stent grafts may be useful because of their excellent trackability and flexibility. After stent placement, dual antiplatelets must be administered for 6 months, followed by lifelong single antiplatelet therapy. In cases of mycotic pseudoaneurysms, placement of a stent graft may be contraindicated (53-55) (Figure 4). Stent-graft placement and branch vessel coil embolization for hepatic artery pseudoaneurysm repair. (A) Pseudoaneurysm of the hepatic artery marked with a black arrow. (B) Successful placement of stent graft (black arrow) across the neck of the pseudoaneurysm after coil embolization (red arrow) of the branch vessel to prevent type 2 endoleak. Flow-diverting stents These multilayer small stents promote progressive thrombosis of the aneurysm by reducing flow in the aneurysm neck, leading to increased blood viscosity within the aneurysm sac and eventual thrombosis. A linear flow into the side branches arising from the aneurysm is preserved through the stent interstices due to neo-endothelialization. Therefore, flow-diverting stents are ideal for complex aneurysms in small arteries (up to 5–5.5 mm). The increased flexibility of the stents also makes them ideal for tortuous anatomy. However, the time to thrombosis of the aneurysm sac with eventual shrinkage is longer than with conventional techniques (5,18). In a meta-analysis including 10 cohort studies with 220 patients, Zhang et al. (56) reported side branch patency of 93% and aneurysm thrombosis/shrinkage in approximately 90% of the cases. As with other stents, dual antiplatelet therapy for 6 months and lifelong single antiplatelet therapy are recommended after stent placement. Direct percutaneous access of the aneurysm and embolization For select cases in which direct access to the aneurysm is available, specifically in cases of saccular aneurysms or pseudoaneurysms with a narrow neck, percutaneous embolization can be performed. In these instances, embolization can be performed under US or CT guidance using a small gauge needle and pushable coils. When percutaneous embolization is performed, liquid embolic agents should be avoided to reduce the risk of nontarget embolization and distal vascular territory (57). Discussion VAAs, once considered rare, are now being increasingly identified because of the widespread use of cross-sectional imaging. This improved detection carries a twofold advantage: first, the identification of asymptomatic aneurysms that might otherwise have remained undiagnosed until rupture; and second, the ability to characterize lesions based on their territory, morphology, and etiology, thus allowing for planned elective interventions or, when appropriate, observation with serial monitoring. However, morphological and etiological heterogeneity can complicate not only the diagnosis of VAAs but also therapeutic decision-making, underscoring the need for individualized, anatomy-specific approaches. Over the past 2 decades, management strategies have shifted from open surgical repair to endovascular techniques, which now constitute the preferred approach in most centers. Endovascular therapy has proven effective for both symptomatic and asymptomatic aneurysms, with asymptomatic cases demonstrating lower 30-day mortality than symptomatic cases (58), likely reflecting the higher rupture rate and hemodynamic instability in symptomatic presentations. In a retrospective study, Gong et al. (59) compared the short-term and medium-term outcomes of coil embolization in symptomatic and asymptomatic VAAs to identify risk factors associated with 30-day mortality. Although perioperative complications were similar in the two groups, 30-day mortality was higher among symptomatic patients, with 2 deaths (9.1%) occurring in patients with symptomatic pseudoaneurysms. These findings highlight the impact of clinical presentation on outcomes and the importance of early detection. In a study assessing the comparative efficacy of the various endovascular techniques for VAAs, Talaie et al. (43) reported a difference in the incidence of endoleaks between self-expanding stents (12.5%) and balloon-expandable stents (60%), supporting the superiority of self-expanding stents. The greater conformability of these stents due to the properties of nitinol enables optimal opposition to the vessel wall. In a systematic review, Kok et al. (60) assessed 22 retrospective cohort studies including 643 endovascularly treated VAAs. The technical success rate was found to be 93.2%, with preservation of distal visceral perfusion reported in 99.3% of cases. Major complications occurred in 3.5% of patients, with a 30-day periprocedural mortality rate of 1.5% and a re-intervention rate of 4.6%. Similarly, Ren et al. (44) reported a technical success rate of 96.9% in 159 patients undergoing endovascular therapy for VAAs, with a 30-day mortality of 1.9% and clinical success in the remaining cohort. Most compellingly, a recent meta-analysis by Rebelo et al. (33) in 4,447 patients demonstrated comparable mortality rates for endovascular repair (1.8%) and open surgery (2.1%), but significantly lower major morbidity (5.6% vs. 8.4%; odds ratio: 0.61, 95% CI: 0.21–1.77; P=0.02) and a 4.3-day reduction in hospital stay with endovascular treatment. In ruptured aneurysms, endovascular therapy was associated with dramatically lower mortality (4.1% vs. 31%) compared to open repair, reinforcing an endovascular-first approach when feasible, albeit with slightly higher 1-year reintervention rates (9% vs. 5%). Similarly, Tipaldi et al. (14) reported 91% technical and clinical success rates in 11 patients with giant VAAs (>5 cm), further supporting the efficacy of endovascular intervention even for challenging lesions. Across all VAA types, open surgical repair remains a viable option when endovascular management is not feasible. Surgery is specifically often a definitive solution in urgent scenarios, such as ruptured aneurysms leading to hemorrhagic shock, or for aneurysms in pregnant individuals. Open repair also offers the advantage of durable aneurysm exclusion with low recurrence and minimal need for reintervention, as evidenced by the markedly lower reintervention rates for open repair than for endovascular treatment in several series (25). That said, open surgery to treat aneurysms in certain anatomic territories carries a higher immediate morbidity risk and may require longer recovery. Conclusions In summary, modern management of VAAs should employ a patient-specific approach: endovascular repair is preferred for its low invasiveness and has shown equivalent survival outcomes for aneurysms in many anatomic territories, but open surgical repair remains crucial for its reliability and ability to address complex presentations. The surgeon’s role is to judiciously choose (and often combine) these tools to maximize patient outcomes. The continued development of endovascular technology and refinement of surgical techniques (including hybrid and laparoscopic methods) promise even better results. However, given the heterogeneity and rarity of VAAs, high-quality data are limited; ongoing accumulation of multicenter experience and meta-analyses will be key. Ultimately, the management of VAAs exemplifies the importance of versatility in vascular surgery, by blending cutting-edge endovascular innovation with time-tested open surgical principles to safely treat these potentially catastrophic aneurysms. Supplementary The article’s supplementary files as Acknowledgments The authors acknowledge editorial support from Megan Griffiths. Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Written informed consent was taken from all the patients for the publications of this study. Footnotes Reporting Checklist: The authors have completed the Narrative Review reporting checklist. Available at https://cdt.amegroups.com/article/view/10.21037/cdt-2025-1-666/rc Funding: None. Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://cdt.amegroups.com/article/view/10.21037/cdt-2025-1-666/coif). The authors have no conflicts of interest to declare. References Available at https://cdt.amegroups.com/article/view/10.21037/cdt-2025-1-666/prf Supplementary Materials The article’s supplementary files as